# To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).

> **NCT02596451** · PHASE3 · COMPLETED · sponsor: **Glenmark Pharmaceuticals Ltd. India** · enrollment: 1164 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Diclofenac Sodium gel, 1%
- **DRUG:** Voltaren® Gel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02596451
- **Lead sponsor:** Glenmark Pharmaceuticals Ltd. India
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 1164 (ACTUAL)
- **Last updated:** 2017-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02596451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02596451, "To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion).". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02596451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*